None listed
Conditions
Interventions
Intervention1: autologus MNCs:
Control Intervention1: NIL: NA
Sponsors
Global Medical Education and Research Center
Eligibility
Inclusion criteria
Inclusion criteria: Ages Eligible for Study: >21 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No ?Established cases of MI with ventricular dysfunction graded. ?No other associated primary disorder such as pulmonary hypertension. ?No associated hematological/infectious diseases.
Exclusion criteria
Exclusion criteria: ? Not willing to participate. ? No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ? Improvement in myocardial function observed in SA node, AV node measured by ECG.Timepoint: | — |
Secondary
| Measure | Time frame |
|---|---|
| ? Safety ? Improvement in LVEF perfusion measured by ECG, 2D-ECHO, Cardiac MRI, Coronary angiography. ? Improved exercise time when observed on the 3rd and 6th month after the therapeutic procedure, when compare to exercise time before the administration of the therapeutic dose. ? Improvement in physical activity. ? Reduction in the use of medicines. Timepoint: 12 months. | — |
Countries
India
Contacts
Public ContactDr.Lakshmi Kiran
INVESTIGATOR
Outcome results
None listed